Spotlight on Fluvoxamine in Anxiety Disorders in Children and Adolescents

被引：0
|
作者：
Susan M. Cheer
David P. Figgitt
机构：
[1] Adis International Limited,
来源：
CNS Drugs | 2002年 / 16卷
关键词：
Anxiety Disorder; Fluvoxamine; Social Phobia; Cisapride; Terfenadine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Fluvoxamine is a selective serotonin reuptake inhibitor (SSRI) which may be used for the management of anxiety disorders in children and adolescents. Absorption of fluvoxamine was similar in adolescents to that in adults, which suggests that the maximum dosage of the drug for patients aged between 12 and 17 years can be as high as 300 mg/day. However, steady-state plasma fluvoxamine concentrations were 2 to 3 times higher in children (aged between 6 and 11 years) than in adolescents; thus, the maximum fluvoxamine dosage recommended for children is 200 mg/day.
引用
收藏
页码：139 / 144
页数：5
相关论文
共 50 条
  • [1] Spotlight on fluvoxamine in anxiety disorders in children and adolescents
    Cheer, SM
    Figgitt, DR
    [J]. CNS DRUGS, 2002, 16 (02) : 139 - 144
  • [2] Fluvoxamine for the treatment of anxiety disorders in children and adolescents
    Walkup, JT
    Labellarte, MJ
    Riddle, MA
    Pine, DS
    Greenhill, L
    Klein, R
    Davies, M
    Sweeney, M
    Abikoff, H
    Hack, S
    Klee, B
    McCracken, J
    Bergman, L
    Piacentini, J
    March, J
    Compton, S
    Robinson, J
    O'Hara, T
    Baker, S
    Vitiello, B
    Ritz, LA
    Roper, M
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (17): : 1279 - 1285
  • [3] Fluvoxamine for the treatment of anxiety disorders in children and adolescents. Reply
    Pine, DS
    Walkup, JT
    Greenhill, L
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (06): : 466 - 467
  • [4] Pilot study: Fluvoxamine treatment for depression and anxiety disorders in children and adolescents with cancer
    Gothelf, D
    Rubinstein, M
    Shemesh, E
    Miller, O
    Farbstein, I
    Klein, A
    Weizman, A
    Apter, A
    Yaniv, I
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2005, 44 (12): : 1258 - 1262
  • [5] Fluvoxamine: A review of its therapeutic potential in the management of anxiety disorders in children and adolescents
    Cheer S.M.
    Figgitt D.P.
    [J]. Paediatric Drugs, 2001, 3 (10): : 763 - 781
  • [6] Anxiety disorders in children and adolescents
    Seva, A
    [J]. EUROPEAN JOURNAL OF PSYCHIATRY, 2002, 16 (02): : 122 - 122
  • [7] Anxiety Disorders in Children and Adolescents
    Kowalchuk, Alicia
    Gonzalez, Sandra J.
    Zoorob, Roger J.
    [J]. AMERICAN FAMILY PHYSICIAN, 2022, 106 (06) : 657 - 664
  • [8] Anxiety Disorders in Children and Adolescents
    Rockhill, Carol
    Kodish, Ian
    DiBattisto, Caroline
    Macias, Michelle
    Varley, Chris
    Ryan, Sheryl
    [J]. CURRENT PROBLEMS IN PEDIATRIC AND ADOLESCENT HEALTH CARE, 2010, 40 (04) : 66 - 99
  • [9] Children and adolescents' anxiety disorders
    Denis, H.
    Baghdadli, A.
    [J]. ARCHIVES DE PEDIATRIE, 2017, 24 (01): : 87 - 90
  • [10] Anxiety disorders in children and adolescents
    Küng, A
    Wieser, E
    Aichhorn, M
    Marksteiner, J
    Aichhorn, W
    [J]. NEUROPSYCHIATRIE, 2005, 19 (03) : 83 - 88
12345